CXCR4 and cancer: This is because overexpression of CXCR4, compared to CXCR4− tumors, is linked to poorer outcomes in cancer patients, including an increase in resistance to chemotherapy, higher risk of recurrence, greater metastasis burden, and shorter progression-free and overall survival [45, 60].